Saunders Issues Statement On Failed Test
Hours after the announcement that he tested positive, Billy Joe Saunders and his promoter have released a statement defending the WBO middleweight champion.
Saunders was found to have oxilofrine in his system, which is a stimulant that helps with increasing adrenaline production and oxygenation of the blood.
Oxilofrine is permitted by USADA for in-competition, and per Saunders’ statement can be used out of competition by U.K. Anti-Doping and in-line with WADA regulations.
Saunders and his promoter Frank Warren claim the failure was due to a common nasal decongestant.
There has been no word on a suspension or cancellation of his fight with Demetrius Andrade on October 20th, but some believe that Saunders may be stripped of his WBO middleweight world championship.
Read the full statement below:
Following reports of an adverse analytical finding in a test carried out by the Voluntary Anti-Doping Association (“VADA”) on WBO World Middleweight Champion, Billy Joe Saunders, we can confirm that the product concerned is permitted to be used ‘Out of Competition’ by United Kingdom Anti-Doping (“UKAD”) in line with the regulations of the World Anti-Doping Agency (“WADA”).
For the avoidance of doubt, the product in question was a common decongestant nasal spray.
The British Boxing Board of Control (“BBBofC”) under whose jurisdiction Billy Joe Saunders is licensed are affiliated only to UKAD/WADA.
Today the BBBofC have confirmed that Mr Saunders is not in breach of BBBofC or UKAD anti-doping regulations and is therefore in good standing and is licensed to box and defend his World Title on October 20th.
Mr. Saunders has been tested a number of times in 2018, all negative, his last out of competition test by UKAD was on 24th September 2018.
Report Via: Boxing Scene